We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$319M
AUM Growth
+$18.9M
Cap. Flow
+$6.94M
Cap. Flow %
2.17%
Top 10 Hldgs %
37.77%
Holding
106
New
6
Increased
17
Reduced
26
Closed
10

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$6.87M
2
IBM icon
IBM
IBM
+$6.33M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.96M
4
SYK icon
Stryker
SYK
+$2.76M
5
CI icon
Cigna
CI
+$2.33M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$3.67M
2
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
+$1.74M
3
IBB icon
iShares Biotechnology ETF
IBB
+$1.38M
4
KKR icon
KKR & Co
KKR
+$1.27M
5
TRGP icon
Targa Resources
TRGP
+$841K

Sector Composition

Rank Sector Weight
1 Healthcare 31.66%
2 Technology 16.82%
3 Communication Services 16.5%
4 Industrials 8.67%
5 Miscellaneous 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FISV
51
Fiserv Inc
FISV
$28.3B
$904K 0.28%
12,200
– –
JNJ icon
52
Johnson & Johnson
JNJ
$646B
$811K 0.25%
6,682
– –
KO icon
53
Coca-Cola
KO
$386B
$789K 0.25%
18,000
– –
BALL icon
54
Ball Corp
BALL
$16.9B
$720K 0.23%
20,260
– –
TROW icon
55
T. Rowe Price
TROW
$23.7B
$688K 0.22%
5,930
– –
FWONA icon
56
Liberty Media Series A
FWONA
$23.4B
$654K 0.2%
19,332
-208
-1% -$6K
FSTX
57
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$620K 0.19%
13,084
– –
MDSO
58
DELISTED
Medidata Solutions, Inc.
MDSO
$596K 0.19%
7,400
– –
GILD icon
59
Gilead Sciences
GILD
$181B
$581K 0.18%
8,207
– –
PH icon
60
Parker-Hannifin
PH
$125B
$581K 0.18%
3,727
– –
LLL
61
DELISTED
L3 Technologies, Inc.
LLL
$577K 0.18%
3,000
– –
CVS icon
62
CVS Health
CVS
$119B
$544K 0.17%
8,450
– –
AEP icon
63
American Electric Power
AEP
$66.6B
$541K 0.17%
7,810
– –
CORI
64
DELISTED
Corium International, Inc.
CORI
$521K 0.16%
+65,000
New +$615K
TSLA icon
65
Tesla
TSLA
$1.38T
$520K 0.16%
+22,725
New +$462K
LSXMK
66
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$485K 0.15%
14,049
– –
LBRDA
67
DELISTED
Liberty Broadband Class A
LBRDA
$440K 0.14%
5,819
-199
-3% -$15K
FWONK icon
68
Liberty Media Series C
FWONK
$25.5B
$428K 0.13%
11,916
-414
-3% -$12.6K
ETP
69
DELISTED
Energy Transfer Partners, L.P.
ETP
$423K 0.13%
22,240
-3,300
-13% -$60.6K
MSFT icon
70
Microsoft
MSFT
$3.81T
$395K 0.12%
4,003
– –
TXN icon
71
Texas Instruments
TXN
$236B
$383K 0.12%
3,475
– –
DISH
72
DELISTED
DISH Network Corp.
DISH
$355K 0.11%
10,550
– –
NGVT icon
73
Ingevity
NGVT
$2.39B
$335K 0.11%
4,147
– –
XLV icon
74
State Street Health Care Select Sector SPDR ETF
XLV
$44.5B
$334K 0.1%
4,000
– –
GS icon
75
Goldman Sachs
GS
$301B
$314K 0.1%
1,425
– –
1 2
3
4

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Private Capital Advisors held 106 positions worth $319M, up 6.3% from $300M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Private Capital Advisors's Q2 2018 filing shows 6 new, 17 increased, 26 reduced and 10 closed positions. Its largest new stake was Karyopharm Therapeutics: 27,793 shares worth $7.08M. The largest sale was Meta Platforms (Facebook), an estimated $3.67M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.

  • Private Capital Advisors's largest Q2 2018 buy was Karyopharm Therapeutics: 27,793 shares worth $7.08M.
  • Private Capital Advisors added most to IBM in Q2 2018, an estimated $6.33M increase.
  • Private Capital Advisors's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $3.67M.
  • Private Capital Advisors fully exited ARMO BioSciences, Inc. Common Stock in Q2 2018, selling an estimated $1.74M.
  • Private Capital Advisors's ten largest holdings make up 38% of its $319M portfolio in Q2 2018.
  • Private Capital Advisors opened 6 new positions and closed 10 in Q2 2018.
  • Private Capital Advisors's portfolio value rose 6.3% quarter-over-quarter to $319M.

Based on Private Capital Advisors's 13F filing for Q2 2018, filed 10 Jul 2018.